Rewisca

Rewisca Special Precautions

pregabalin

Manufacturer:

Krka

Distributor:

Hind Wing
Full Prescribing Info
Special Precautions
Talk to the doctor or pharmacist before taking Rewisca.
Some patients taking Rewisca have reported symptoms suggesting an allergic reaction. These symptoms include swelling of the face, lips, tongue, and throat, as well as diffuse skin rash. Should any of these reactions be experienced, the patient should contact the physician immediately.
Rewisca has been associated with dizziness and somnolence, which could increase the occurrence of accidental injury (fall) in elderly patients. Therefore, the patient should be careful until he/she is used to any effect the medicine might have.
Rewisca may cause blurring or loss of vision, or other changes in eyesight, many of which are temporary. Immediately tell the doctor if experiencing any changes in vision.
Some patients with diabetes who gain weight while taking pregabalin may need an alteration in their diabetic medicines.
Certain side effects may be more common, such as sleepiness, because patients with spinal cord injury may be taking other medicines to treat, for example, pain or spasticity, that have similar side effects to pregabalin and the severity of these effects may be increased when taken together.
There have been reports of heart failure in some patients when taking Rewisca; these patients were mostly elderly with cardiovascular conditions. Before taking this medicine, the patient should tell the doctor if he/she has a history of heart disease.
There have been reports of kidney failure in some patients when taking Rewisca. If while taking Rewisca decreased urination is noticed, the patient should tell the doctor as stopping the medicine may improve this.
A small number of people being treated with anti-epileptics such as Rewisca have had thoughts of harming or killing themselves. If at any time the patient has these thoughts, he/she should immediately contact the doctor.
When Rewisca is taken with other medicines that may cause constipation (such as some types of pain medicines), it is possible that gastrointestinal problems may occur (e.g. constipation, blocked or paralysed bowel). Tell the doctor if experiencing constipation, especially if prone to this problem.
Before taking this medicine, the patient should tell the doctor if he/she has a history of alcoholism or any drug abuse or dependence. The patient should not take more medicine than prescribed.
There have been reports of convulsions when taking Rewisca or shortly after stopping Rewisca. If a convulsion is experienced, contact the doctor immediately.
There have been reports of reduction in brain function (encephalopathy) in some patients taking Rewisca when they have other conditions. The patient should tell the doctor if he/she has a history of any serious medical conditions, including liver or kidney disease.
Driving and using machines: Rewisca may produce dizziness, sleepiness and decreased concentration. Do not drive, operate complex machinery or engage in other potentially hazardous activities until it is known whether this medicine affects the ability to perform these activities.
Use in Children: The safety and efficacy in children and adolescents (under 18 years of age) has not been established and therefore, pregabalin should not be used in this age group.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in